Google is turning its vast public data trove into a goldmine for AI with the debut of the Data Commons Model Context Protocol (MCP) Server — enabling developers, data scientists, and AI agents to ...
Non-profit organisation MS Society SA & NT, says it has debts of about $2.5 million and has been facing losses for three years. The organisation which supports between 2,000 and 3,000 people and ...
Norwegian firm ASP Data Center has acquired a former factory and cryptomine, and plans to turn it into an AI data center. The company recently announced the acquisition of a former factory used by ...
Vinayak Shukla, a wicketkeeper from Kanpur, overcame obstacles to represent Oman in the ongoing Asia Cup after moving in 2021. Balancing his job as a Data Operator with cricket, Shukla debuted for ...
Sheikha Mahra bint Mohammed Rashed Al Maktoum, a princess of Dubai, has made a name for herself over the years as an educated and accomplished entrepreneur, royal and mother of one daughter. In August ...
Kilmar Abrego Garcia, the Salvadorian migrant whose months-long court fight has emerged as a flashpoint of the Trump administration's immigration crackdown, will report Monday to the ICE Field Office ...
MSNBC will change its name to MS NOW later this year as part of its split from NBC News, prompting criticism and mockery across social media. The rebranding — which stands for My Source for News, ...
National Public Data was the target of a massive hack in early 2024, which led to billions of records being leaked. The site has since returned under new ownership. The site now allows you to search ...
The Bureau of Labor Statistics is reducing or ending the collection of data that is used to calculate the Consumer Price Index. By Ben Casselman Federal Reserve policymakers have stressed that their ...
ProPublica is a nonprofit newsroom that investigates abuses of power. Sign up to receive our biggest stories as soon as they’re published. These highlights were written by the reporters and editors ...
Almost two years of treatment with fenebrutinib — an investigational oral tablet for multiple sclerosis (MS) — helped patients with relapsing forms of the disease remain nearly free of relapses and ...